Disease ID |
Disease Name |
Direct Evidence |
Inference Chemical Name |
Inference Score |
Publication |
---|
MESH:D055371 |
Acute Lung Injury |
|
pirinixic acid |
3.42 | 18653653 |
MESH:D000230 |
Adenocarcinoma |
|
Doxorubicin |
2.62 | 17418594 |
MESH:D018248 |
Adenoma, Liver Cell |
|
pirinixic acid |
3.88 | 16434500 |
MESH:D018246 |
Adrenocortical Adenoma |
|
Arsenic |
5.66 | 17306315 |
MESH:D000419 |
Albuminuria |
|
Doxorubicin |
4.87 | 21441931 |
MESH:D020261 |
Arsenic Poisoning |
|
Arsenic |
2.93 | 16251483 12569548 16835338 18414634 |
MESH:D050197 |
Atherosclerosis |
|
Arsenic |
3.40 | 12928151 19371607 |
MESH:D001289 |
Attention Deficit Disorder with Hyperactivity |
|
Phthalic Acids |
4.54 | 20106747 |
MESH:D001321 |
Autistic Disorder |
|
Choline |
3.33 | 16818868 |
MESH:D001778 |
Blood Coagulation Disorders |
|
pirinixic acid |
3.43 | 19483382 |
MESH:D019046 |
Bone Marrow Neoplasms |
|
Doxorubicin |
5.14 | 14601052 |
MESH:D001862 |
Bone Resorption |
|
bisphenol A |
4.14 | 11985600 |
MESH:D001932 |
Brain Neoplasms |
|
Doxorubicin |
4.07 | 17150277 |
MESH:D001943 |
Breast Neoplasms |
|
bisphenol A |
2.36 | 17123778 |
MESH:D001943 |
Breast Neoplasms |
|
Doxorubicin |
2.36 | 16595493 16264153 15634643 18382427 16935488 18628466 16115903 15939500 16322301 18695136 11325840 15136595 15668708 15994142 16826403 16096432 18234424 17369602 15993339 17983394 17426702 15567936 19526202 15692762 |
MESH:D002276 |
Carcinoid Tumor |
|
Doxorubicin |
5.25 | 16051944 |
MESH:D002280 |
Carcinoma, Basal Cell |
|
Arsenic |
3.73 | 15504454 17687452 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Arsenic |
3.43 | 16507464 17306315 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Doxorubicin |
3.43 | 18059187 17876044 16023760 16234567 |
MESH:D002278 |
Carcinoma in Situ |
|
bisphenol A |
5.38 | 17123778 |
MESH:D002292 |
Carcinoma, Renal Cell |
|
Doxorubicin |
3.27 | 16201981 1485588 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
Arsenic |
5.15 | 15504454 18922899 17687452 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
Doxorubicin |
5.15 | 6189445 |
MESH:D002295 |
Carcinoma, Transitional Cell |
|
Arsenic |
4.34 | 18640142 |
MESH:D009202 |
Cardiomyopathies |
|
Doxorubicin |
3.70 | 17928571 16109756 16455267 15476868 16242529 17329180 17974986 17519947 16278810 17131338 16952015 17382496 16612575 16651473 17924179 15505089 17007740 15811867 15792986 16269455 18627295 17308081 16364871 16731534 17351982 |
MESH:D002311 |
Cardiomyopathy, Dilated |
|
Doxorubicin |
3.02 | 17334414 16243910 |
MESH:D002318 |
Cardiovascular Diseases |
|
Arsenic |
3.63 | 15738583 17938729 19152805 |
MESH:D002340 |
Carotid Artery Diseases |
|
Arsenic |
4.56 | 18022660 16973168 |
MESH:D002779 |
Cholestasis |
|
pirinixic acid |
3.03 | 19176532 |
MESH:D015179 |
Colorectal Neoplasms |
|
Doxorubicin |
2.14 | 18259882 18802399 |
MESH:D003876 |
Dermatitis, Atopic |
|
pirinixic acid |
2.53 | 18249437 |
MESH:D002658 |
Developmental Disabilities |
|
Choline |
4.85 | 16818868 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Doxorubicin |
2.50 | 17416283 |
MESH:D004362 |
Drug Toxicity |
|
Doxorubicin |
3.87 | 18602426 |
MESH:D004487 |
Edema |
|
pirinixic acid |
2.76 | 12083418 |
MESH:D016889 |
Endometrial Neoplasms |
|
Doxorubicin |
3.62 | 17359293 |
MESH:D004719 |
Endomyocardial Fibrosis |
|
Doxorubicin |
5.60 | 18037988 |
MESH:D005234 |
Fatty Liver |
|
pirinixic acid |
3.04 | 20131406 19236843 |
MESH:D018222 |
Fibromatosis, Aggressive |
|
Doxorubicin |
4.98 | 19069698 |
MESH:D005534 |
Foot Diseases |
|
Arsenic |
6.00 | 6392382 |
MESH:D005909 |
Glioblastoma |
|
Doxorubicin |
3.52 | 17150277 |
MESH:D006258 |
Head and Neck Neoplasms |
|
Doxorubicin |
3.70 | 15692506 |
MESH:D006331 |
Heart Diseases |
|
Doxorubicin |
3.67 | 16495754 16244371 14766674 18674790 18006777 16330681 17875725 16144979 16244372 17888722 16879835 12587719 16707910 |
MESH:D006333 |
Heart Failure |
|
Doxorubicin |
7.58 | 17481944 |
MESH:D006333 |
Heart Failure |
|
pirinixic acid |
7.58 | 20558911 |
MESH:D006394 |
Hemangiosarcoma |
|
Doxorubicin |
4.18 | 15692506 |
MESH:D006529 |
Hepatomegaly |
|
pirinixic acid |
3.35 | 16221962 18467677 19772884 19176532 |
MESH:D006689 |
Hodgkin Disease |
|
Doxorubicin |
3.65 | 18501091 15147373 17606976 |
MESH:D006943 |
Hyperglycemia |
|
pirinixic acid |
3.45 | 20558911 |
MESH:D017488 |
Hyperkeratosis, Epidermolytic |
|
Arsenic |
4.72 | 17050553 |
MESH:D006973 |
Hypertension |
|
Arsenic |
2.95 | 16076760 11953799 9931084 |
MESH:D006987 |
Hypesthesia |
|
Arsenic |
6.00 | 16093927 |
MESH:D007333 |
Insulin Resistance |
|
bisphenol A |
7.88 | 16393666 |
MESH:D007333 |
Insulin Resistance |
|
pirinixic acid |
7.88 | 16306350 |
MESH:D007642 |
Keratosis |
|
Arsenic |
5.39 | 12749816 16930632 |
MESH:D007674 |
Kidney Diseases |
|
Doxorubicin |
3.20 | 15699352 15369732 16775033 |
MESH:D007676 |
Kidney Failure, Chronic |
|
Doxorubicin |
4.44 | 16707910 |
MESH:D004915 |
Leukemia, Erythroblastic, Acute |
|
Doxorubicin |
5.60 | 16085563 |
MESH:D015473 |
Leukemia, Promyelocytic, Acute |
|
Arsenic |
3.72 | 17339181 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Doxorubicin |
2.54 | 16595196 16439617 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
pirinixic acid |
2.54 | 15474484 |
MESH:D008107 |
Liver Diseases |
|
Arsenic |
2.59 | 11134558 |
MESH:D008113 |
Liver Neoplasms |
|
Arsenic |
4.90 | 16368122 |
MESH:D008113 |
Liver Neoplasms |
|
pirinixic acid |
4.90 | 20007298 15890375 16377806 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Doxorubicin |
3.17 | 17085340 16842330 |
MESH:D008175 |
Lung Neoplasms |
|
Arsenic |
2.82 | 17306315 17976673 19168569 |
MESH:D008175 |
Lung Neoplasms |
|
Doxorubicin |
2.82 | 17418594 6189445 |
MESH:D008223 |
Lymphoma |
|
Doxorubicin |
3.65 | 16098063 |
MESH:D008228 |
Lymphoma, Non-Hodgkin |
|
Doxorubicin |
4.02 | 17654614 |
MESH:D016399 |
Lymphoma, T-Cell |
|
Doxorubicin |
4.93 | 15621674 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
Doxorubicin |
3.19 | 15458769 |
MESH:D008545 |
Melanoma |
|
Doxorubicin |
2.32 | 16827129 |
MESH:D008654 |
Mesothelioma |
|
Doxorubicin |
3.15 | 17638057 |
MESH:D028361 |
Mitochondrial Diseases |
|
Doxorubicin |
4.78 | 15792986 |
MESH:D052016 |
Mucositis |
|
Doxorubicin |
5.19 | 17415656 |
MESH:D009135 |
Muscular Diseases |
|
pirinixic acid |
3.86 | 16239165 |
MESH:D009203 |
Myocardial Infarction |
|
Doxorubicin |
6.04 | 19429709 15857846 |
MESH:D009203 |
Myocardial Infarction |
|
pirinixic acid |
6.04 | 19151258 |
MESH:D017202 |
Myocardial Ischemia |
|
Arsenic |
4.21 | 15371236 |
MESH:D015428 |
Myocardial Reperfusion Injury |
|
pirinixic acid |
3.16 | 16411023 |
MESH:D009362 |
Neoplasm Metastasis |
|
Doxorubicin |
3.04 | 18259882 |
MESH:D009369 |
Neoplasms |
|
pirinixic acid |
2.06 | 17405874 |
MESH:D009401 |
Nephrosis |
|
Doxorubicin |
5.13 | 16636307 16899518 |
MESH:D009404 |
Nephrotic Syndrome |
|
Doxorubicin |
4.25 | 16889571 15640375 |
MESH:D009421 |
Nervous System Malformations |
|
bisphenol A |
4.30 | 11399458 16427766 |
MESH:D009436 |
Neural Tube Defects |
|
Arsenic |
3.62 | 16620997 |
MESH:D009447 |
Neuroblastoma |
|
Doxorubicin |
3.39 | 15555623 |
MESH:D020078 |
Neurogenic Inflammation |
|
Arsenic |
4.68 | 17056641 |
MESH:D009765 |
Obesity |
|
pirinixic acid |
1.86 | 20558911 |
MESH:D012516 |
Osteosarcoma |
|
Doxorubicin |
4.34 | 15930896 |
MESH:D010049 |
Ovarian Diseases |
|
bisphenol A |
5.38 | 11985600 |
MESH:D010051 |
Ovarian Neoplasms |
|
Arsenic |
2.81 | 17306315 |
MESH:D010523 |
Peripheral Nervous System Diseases |
|
Arsenic |
4.51 | 16093927 |
MESH:D016491 |
Peripheral Vascular Diseases |
|
Arsenic |
5.39 | 15371236 16905509 6392382 |
MESH:D003557 |
Phyllodes Tumor |
|
Doxorubicin |
5.60 | 17983394 |
MESH:D010997 |
Pleural Neoplasms |
|
Doxorubicin |
5.60 | 17638057 |
MESH:D011297 |
Prenatal Exposure Delayed Effects |
|
bisphenol A |
4.35 | 10548101 |
MESH:D019048 |
Prostatic Intraepithelial Neoplasia |
|
bisphenol A |
4.49 | 20887781 |
MESH:D011471 |
Prostatic Neoplasms |
|
Arsenic |
2.64 | 16140617 |
MESH:D011471 |
Prostatic Neoplasms |
|
bisphenol A |
2.64 | 16740699 |
MESH:D011471 |
Prostatic Neoplasms |
|
Doxorubicin |
2.64 | 16868541 18437689 15749863 15897917 16888761 16729912 |
MESH:D011507 |
Proteinuria |
|
Arsenic |
4.31 | 21343184 |
MESH:D011629 |
Puberty, Precocious |
|
bisphenol A |
5.18 | 10548101 |
MESH:D051437 |
Renal Insufficiency |
|
Doxorubicin |
4.58 | 17922066 |
MESH:D015427 |
Reperfusion Injury |
|
pirinixic acid |
2.50 | 19058328 |
MESH:D012509 |
Sarcoma |
|
Doxorubicin |
4.25 | 16767912 17203757 15625365 17710206 18313854 15675481 |
MESH:D012512 |
Sarcoma, Ewing's |
|
Doxorubicin |
4.57 | 14601052 16326096 |
MESH:D012514 |
Sarcoma, Kaposi |
|
Doxorubicin |
5.19 | 17846226 |
MESH:D012871 |
Skin Diseases |
|
Arsenic |
2.80 | 17548696 17453740 19834688 17050553 15952646 16759981 16702368 17938729 18709164 6392382 16353154 |
MESH:D012878 |
Skin Neoplasms |
|
Arsenic |
6.42 | 17029826 17050553 17976673 19538983 16251483 15504454 |
MESH:D012878 |
Skin Neoplasms |
|
Doxorubicin |
6.42 | 15692506 |
MESH:D012983 |
Soft Tissue Neoplasms |
|
Doxorubicin |
4.93 | 16767912 15625365 17203757 |
MESH:D019966 |
Substance-Related Disorders |
|
bisphenol A |
4.38 | 16045194 16684133 |
MESH:D013964 |
Thyroid Neoplasms |
|
Doxorubicin |
3.58 | 16010429 17909728 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
Arsenic |
5.69 | 17306315 11144890 19429237 15987713 18640142 19322015 17976673 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
Doxorubicin |
5.69 | 17653716 |
MESH:D014591 |
Uterine Diseases |
|
bisphenol A |
5.45 | 14652134 |
MESH:D014652 |
Vascular Diseases |
|
Arsenic |
5.13 | 17056641 |
MESH:D018487 |
Ventricular Dysfunction, Left |
|
Doxorubicin |
4.58 | 17638931 17334414 16364871 17678736 |